Agendia, Agilent to Develop Dx Tests, Extend Supply Pact | GenomeWeb
NEW YORK (GenomeWeb News) – Agendia and Agilent Technologies announced today that they have extended a supply agreement and intend to collaborate on the development of new in vitro diagnostic tests.
 
According to a joint statement, the firms will collaborate on developing cancer diagnostic tests that will be run on Agilent microarrays.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.